Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3.

Wolf RM, Draghi N, Liang X, Dai C, Uhrbom L, Eklöf C, Westermark B, Holland EC, Resh MD.

Genes Dev. 2003 Feb 15;17(4):476-87.

2.
3.

Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells.

Uhrbom L, Hesselager G, Ostman A, Nistér M, Westermark B.

Int J Cancer. 2000 Feb 1;85(3):398-406.

4.

Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses.

Assanah M, Lochhead R, Ogden A, Bruce J, Goldman J, Canoll P.

J Neurosci. 2006 Jun 21;26(25):6781-90.

5.

Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.

Ferletta M, Uhrbom L, Olofsson T, Pontén F, Westermark B.

Mol Cancer Res. 2007 Sep;5(9):891-7.

7.

p190-A, a human tumor suppressor gene, maps to the chromosomal region 19q13.3 that is reportedly deleted in some gliomas.

Tikoo A, Czekay S, Viars C, White S, Heath JK, Arden K, Maruta H.

Gene. 2000 Oct 17;257(1):23-31.

PMID:
11054565
8.

p27 deficiency is associated with migration defects in PDGF-expressing gliomas in vivo.

See WL, Heinberg AR, Holland EC, Resh MD.

Cell Cycle. 2010 Apr 15;9(8):1562-7. Epub 2010 Apr 15.

PMID:
20404478
9.

p190RhoGAP is cell cycle regulated and affects cytokinesis.

Su L, Agati JM, Parsons SJ.

J Cell Biol. 2003 Nov 10;163(3):571-82.

10.

Antagonistic modulation of gliomagenesis by Pax6 and Olig2 in PDGF-induced oligodendroglioma.

Appolloni I, Calzolari F, Barilari M, Terrile M, Daga A, Malatesta P.

Int J Cancer. 2012 Oct 1;131(7):E1078-87. doi: 10.1002/ijc.27606. Epub 2012 May 17.

11.

EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.

Alaminos M, Dávalos V, Ropero S, Setién F, Paz MF, Herranz M, Fraga MF, Mora J, Cheung NK, Gerald WL, Esteller M.

Cancer Res. 2005 Apr 1;65(7):2565-71.

12.

Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma.

Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L.

Oncogene. 2009 Jun 11;28(23):2266-75. doi: 10.1038/onc.2009.76. Epub 2009 Apr 27.

PMID:
19421151
13.
14.

Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.

von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR.

Cancer Res. 1992 Aug 1;52(15):4277-9.

15.

Recent insights into PDGF-induced gliomagenesis.

Calzolari F, Malatesta P.

Brain Pathol. 2010 May;20(3):527-38. doi: 10.1111/j.1750-3639.2009.00335.x. Epub 2009 Sep 25. Review.

PMID:
19832839
16.
17.

Retroviral delivery of platelet-derived growth factor to spinal cord progenitor cells drives the formation of intramedullary gliomas.

Ellis JA, Castelli M, Bruce JN, Canoll P, Ogden AT.

Neurosurgery. 2012 Jan;70(1):198-204; discussion 204. doi: 10.1227/NEU.0b013e31822ce963.

18.

Platelet-derived growth factor in human glioma.

Westermark B, Heldin CH, Nistér M.

Glia. 1995 Nov;15(3):257-63. Review.

PMID:
8586462
19.

EGFRvIII expression and PTEN loss synergistically induce chromosomal instability and glial tumors.

Li L, Dutra A, Pak E, Labrie JE 3rd, Gerstein RM, Pandolfi PP, Recht LD, Ross AH.

Neuro Oncol. 2009 Feb;11(1):9-21. doi: 10.1215/15228517-2008-081. Epub 2008 Sep 23.

20.

Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas.

Becher OJ, Hambardzumyan D, Fomchenko EI, Momota H, Mainwaring L, Bleau AM, Katz AM, Edgar M, Kenney AM, Cordon-Cardo C, Blasberg RG, Holland EC.

Cancer Res. 2008 Apr 1;68(7):2241-9. doi: 10.1158/0008-5472.CAN-07-6350.

Supplemental Content

Support Center